SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways

por Zhou, T T, Quan, L L, Chen, L P, Du, T, Sun, K X, Zhang, J C, Yu, L, Li, Y, Wan, P, Chen, L L, Jiang, B H, Hu, L H, Chen, J, Shen, X
Publicado 2016